Jazz Pharmaceuticals Plc (JAZZ)
214.00
-0.65
(-0.30%)
USD |
NASDAQ |
Oct 23, 16:00
213.02
-0.98
(-0.46%)
Pre-Market: 20:00
Jazz Pharmaceuticals Market Cap : 13.87B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 13.87B |
| October 22, 2026 | 13.91B |
| October 21, 2026 | 13.74B |
| October 20, 2026 | 13.85B |
| October 19, 2026 | 13.51B |
| October 16, 2026 | 13.62B |
| October 15, 2026 | 13.89B |
| October 14, 2026 | 13.59B |
| October 13, 2026 | 13.63B |
| October 12, 2026 | 14.05B |
| October 09, 2026 | 14.15B |
| October 08, 2026 | 14.41B |
| October 07, 2026 | 14.98B |
| October 06, 2026 | 14.99B |
| October 05, 2026 | 15.30B |
| October 02, 2026 | 15.27B |
| October 01, 2026 | 15.10B |
| September 30, 2026 | 15.00B |
| September 29, 2026 | 15.06B |
| September 28, 2026 | 15.44B |
| September 25, 2026 | 15.42B |
| September 24, 2026 | 15.31B |
| September 23, 2026 | 15.22B |
| September 22, 2026 | 15.59B |
| September 21, 2026 | 15.65B |
| Date | Value |
|---|---|
| September 18, 2026 | 15.60B |
| September 17, 2026 | 15.80B |
| September 16, 2026 | 15.78B |
| September 15, 2026 | 15.61B |
| September 14, 2026 | 15.93B |
| September 11, 2026 | 15.93B |
| September 10, 2026 | 15.58B |
| September 09, 2026 | 15.64B |
| September 08, 2026 | 15.56B |
| September 04, 2026 | 15.99B |
| September 03, 2026 | 16.04B |
| September 02, 2026 | 15.91B |
| September 01, 2026 | 15.79B |
| August 31, 2026 | 16.24B |
| August 28, 2026 | 15.85B |
| August 27, 2026 | 16.27B |
| August 26, 2026 | 16.15B |
| August 25, 2026 | 16.86B |
| August 24, 2026 | 16.49B |
| August 21, 2026 | 16.48B |
| August 20, 2026 | 16.12B |
| August 19, 2026 | 16.34B |
| August 18, 2026 | 16.40B |
| August 17, 2026 | 16.09B |
| August 14, 2026 | 15.87B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Avadel Pharmaceuticals Plc | 2.104B |
| GH Research Plc | 1.240B |
| Cosmo NV | 1.100B |
| Corcept Therapeutics, Inc. | 9.266B |
| Eli Lilly & Co. | 1.199T |
Market Cap Related Metrics
| PE Ratio | 14.76 |
| PS Ratio | 3.029 |
| Price to Book Value | 2.888 |
| Price to Free Cash Flow | 9.244 |
| Price | 214.00 |
| Earnings Yield | 6.78% |
| Operating PE Ratio | 14.60 |
| Normalized PE Ratio | 12.84 |